Fig. 1: JM2 inhibited tumor growth in vivo. | Cell Death & Disease

Fig. 1: JM2 inhibited tumor growth in vivo.

From: Juxtamembrane 2 mimic peptide competitively inhibits mitochondrial trafficking and activates ROS-mediated apoptosis pathway to exert anti-tumor effects

Fig. 1: JM2 inhibited tumor growth in vivo.The alternative text for this image may have been generated using AI.

a Schematic illustration of the in vivo anti-tumor experimental protocol. b Representative images of tumors in Control and JM2 groups at day 14. c Tumor volume at each time interval measured during treatment. d Body weight curve of mice monitored during treatment. e H&E staining of tumors obtained from Control and JM2 groups at day 14. f Ki67 immunohistochemical staining (brown) of tumors obtained from Control and JM2 groups at day 14. g TUNEL staining (green) and DAPI staining (blue) of tumors obtained from Control and JM2 groups at day 14.

Back to article page